Author

Sabrina Tosi

Brunel University of LondonORCID 0000-0002-0036-0191Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alice GiustacchiniiD· 1 shared Ayona Johns· 1 shared Chun-Wai Wade SueniD· 1 shared Cristina PinaiD· 1 shared Denise RagusaiD· 1 shared Emily M. Johnson· 1 shared Gabriel Torregrosa-CortésiD· 1 shared Macarena Oporto EspuelasiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alice GiustacchiniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Integrated in silico and in vitro approaches identify a HSP90 drug vulnerability axis in t(7;12) infant leukemia stem-like cells

Ylenia Cicirò, Denise Ragusa, Emily M. Johnson, Ayona Johns, Sina Kanannejad, Remisha Gurung, Macarena Oporto Espuelas, Chun-Wai Wade Suen, Gabriel Torregrosa-Cortés, Alice Giustacchini, Sabrina Tosi, Cristina Pina

The paper identifies HSP90 inhibitors as potential therapies for t(7;12)-AML by combining computational drug screening with in vitro experiments.

bioRxiv · Sep 6, 2025 · PreprintCancer Biology